Slingshot Insights

Catalyst

Slingshot members are tracking this event:

Portola (PTLA) Expects European Medicines Agency Decision on Betrixaban in Q1 2018

Source Link:: http://investors.portola.com/phoenix.zhtml?c=198136&p=irol-calendar

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

PTLA

100%

SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details Update on Dec 12 2017: The CHMP has provided the Day 195 List of Outstanding Issues (LoOI) to the company with a request for responses during the next available submission window of January 23, 2018. Based on this new timeline, the Company expects the CHMP to issue an opinion later in the first quarter of 2018.

http://investors.por...

Slingshot Insights Explained

JOIN FOR FREE TODAY

Catalyst Date

Occurred on:

Mar 23, 2018

Occurred Source:

http://investors.portola.com/phoenix.zhtml?c=198136&p=irol-newsArticle&ID=2339496

Related Projects

Don’t see a project related to the catalyst you care about?

Related Keywords European Medicines Agency, Decision, Betrixaban, Prevention Of Vte, Acute Medically Ill Patients